Effect of recombinant human erythropoietin on capillary density in acute myocardial infarction region and ischemic region

Zhang Yu-qing,Zhang Fu-min,Zhang Ding-guo,Zhou Lei,Yao Jing,Chen Yi-jiang,Chang Zai,Gao Xiang,Li Chuan-fu,Ha Tuan-zhu
DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.09.029
2006-01-01
Abstract:AIM Recombinant human erythropoietin is used to treat acute myocardial infarction of the rats then to observe its effect on cellular apoptosis in the region of myocardial infarction as well as capillary density of ischemic region and cardiac function.METHODS This experiment was conducted at the Research Institute of Model Animals of Nanjing University from June 2004 to June 2005. Totally 16 healthy male Wistar rats were chosen and randomly divided into acute myocardial infarction group n=8 and recombinant human erythropoietin group n=8. ①Rat models were created by ligating the left anterior descending coronary artery LAD in the two groups local myocardium was purple and bulge of ventricular wall marked the model was successful. ② 3 000 IU/ kg recombinant human erythropoietin was intraperitoneally injected into the rats in the recombinant human erythropoietin group every day during perioperative period 3 days in total one day before operation on the day of the operation 1 day after operation. Same volume of recombinant human erythropoietin was injected successively on postoperative days 14 15 and 16. The rats in the acute myocardial infarction group were given the same volume of normal saline at each time point. ③After ligating LAD capillary density the level of Bcl-2 and Bax of ischemic region were determined at the end of the third week. Structure of cardiac cavity and cardiac function of the rats in the two groups were examined with two-dimensional echocardiogram on day 2 and at the end of the third week. RESULTS All the 16 rats enrolled in the experiment entered the stage of result analysis. ①Measuring result of capillary density of the rats at the end of the third week after operation capillary density of recombinant human erythropoietin was obviously increased as compared with acute myocardial infarction group (10.4±1.5) vs (6.3±0.7)/field,P < 0.05 . ② Expression of Bcl-2 and Bax protein of cardiac tissue at the end of the third week after operation in the two groups As compared with acute myocardial infarction group Bax expression of recombinant human erythropoietin was obviously decreased (0.146 5±0.013 8)vs(0.1248±0.009 8) A,P < 0.05 ,while Bcl-2 expression was obviously increased (0.103 0 ±0.005 6)vs(0.116 3±0.005 0) A,P < 0.05 . ③ Change of cardiac function and other indexes at the end of the third week after operation of the two groups left ventricular diastolic diameter LVEDD and left ventricular end-diastolic diameter LVESDD of recombinant human erythropoietin group was all significantly decreased as compared with acute myocardial infarction group (6.25±0.32)vs(5.51±0.35) mm;(4.22±0.21)vs(3.45±0.24) mm;both P < 0.05 ,while left ventrical ejection fraction was significantly increased 69.08±2.23% vs (75.24±3.64)%,P < 0.05 .CONCLUSION Recombinant human erythropoietin can reduce ventricular cellular apoptosis of ischemic region and promote vascularization of ischemic region so as to improve and enhance cardiac function of myocardial infarction rats.
What problem does this paper attempt to address?